- Home
- WCN vs EW Comparison
WCN vs EW Comparison
Compare WCN & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WCN
- EW
- Stock Information
- Founded
- WCN 1997
- EW 1958
- Country
- WCN Canada
- EW United States
- Employees
- WCN N/A
- EW N/A
- Industry
- WCN Power Generation
- EW Industrial Specialties
- Sector
- WCN Utilities
- EW Health Care
- Exchange
- WCN Nasdaq
- EW Nasdaq
- Market Cap
- WCN 43.2B
- EW 45.5B
- IPO Year
- WCN 1998
- EW 2000
- Fundamental
- Price
- WCN $175.47
- EW $85.12
- Analyst Decision
- WCN Strong Buy
- EW Buy
- Analyst Count
- WCN 18
- EW 19
- Target Price
- WCN $210.22
- EW $92.35
- AVG Volume (30 Days)
- WCN 1.3M
- EW 5.2M
- Earning Date
- WCN 10-21-2025
- EW 10-30-2025
- Dividend Yield
- WCN 0.73%
- EW N/A
- EPS Growth
- WCN N/A
- EW N/A
- EPS
- WCN 2.40
- EW 2.33
- Revenue
- WCN $9,353,892,000.00
- EW $5,883,800,000.00
- Revenue This Year
- WCN $7.15
- EW $13.96
- Revenue Next Year
- WCN $5.82
- EW $9.81
- P/E Ratio
- WCN $73.06
- EW $37.24
- Revenue Growth
- WCN 7.58
- EW 10.60
- 52 Week Low
- WCN $163.27
- EW $65.94
- 52 Week High
- WCN $201.66
- EW $87.21
- Technical
- Relative Strength Index (RSI)
- WCN 59.61
- EW 60.54
- Support Level
- WCN $166.41
- EW $83.32
- Resistance Level
- WCN $170.35
- EW $86.86
- Average True Range (ATR)
- WCN 2.84
- EW 1.83
- MACD
- WCN 1.11
- EW -0.14
- Stochastic Oscillator
- WCN 95.29
- EW 62.56
About WCN Waste Connections Inc.
Waste Connections is the third-largest integrated provider of traditional solid waste and recycling services in North America, operating 113 active landfills (20 are exploration and production waste landfills and 16 are nonmunicipal waste landfills), 163 transfer stations, and 89 recycling operations. The firm serves residential, commercial, industrial, and energy end markets. Waste Connections entered the Canadian market via its 2016 merger with Progressive Waste. In 2024, 14% of consolidated revenue was generated from the firm's Canadian segment.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.